Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
From MaRDI portal
(Redirected from Publication:4935354)
Recommendations
- Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
- Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
- Estimating Lead Time and Sensitivity in a Screening Program without Estimating the Incidence in the Screened Group
- How well can screening sensitivity and sojourn time be estimated
- Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
Cited in
(27)- Testing the Independence of Two Diagnostic Tests
- Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases
- Beta prime regression with application to risky behavior frequency screening
- A note on the catch-up time method for estimating lead or sojourn time in prostate cancer screening
- Identifiability of the joint distribution of age and tumor size at detection in the presence of screening
- MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening
- A review of estimation of key parameters and lead time in cancer screening
- Gamma process-based models for disease progression
- Planning of randomized early detection trials
- Proportional Hazards Regression for Cancer Studies
- Simplified Models of Screening for Chronic Disease: Estimation Procedures from Mass Screening Programmes
- Designing cancer screening trials for reduction in late-stage cancer incidence
- Mortality Modeling of Early Detection Programs
- Estimation and Prediction for Cancer Screening Models Using Deconvolution and Smoothing
- Random effects models of tumour growth for investigating interval breast cancer
- scientific article; zbMATH DE number 3956291 (Why is no real title available?)
- Screening for a chronic disease: a multiple stage duration model with partial observability
- Tailored optimal posttreatment surveillance for cancer recurrence
- A Note on the Sensitivities of Self-reporting and Screen Detection of Primary Breast Tumours
- A Conditional Approach to Measure Mortality Reductions Due to Cancer Screening
- Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution
- Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
- Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial
- Multivariate distributions of clinical covariates at the time of cancer detection
- Instrumental variable estimation of early treatment effect in randomized screening trials
- Quantification of length-bias in screening trials with covariate-dependent test sensitivity
- An Early‐ and Late‐Stage Convolution Model for Disease Natural History
This page was built for publication: Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4935354)